CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,055 Cr | ₹1,200 Cr | ₹1,017 Cr | ₹853 Cr | ₹713 Cr |
What is the latest Revenue of CONCORD BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,055 Cr |
| Mar2025 | ₹1,200 Cr |
| Mar2024 | ₹1,017 Cr |
| Mar2023 | ₹853 Cr |
| Mar2022 | ₹713 Cr |
How is Revenue of CONCORD BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,055 Cr | -12.10 | |
| Mar2025 | ₹1,200 Cr | 18.01 | |
| Mar2024 | ₹1,017 Cr | 19.20 | |
| Mar2023 | ₹853 Cr | 19.67 | |
| Mar2022 | ₹713 Cr | - | |
Compare Revenue of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹15,451.0 Cr | -1.1% | -4.6% | -5.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.1% |
-4.6% |
-5.8% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses